Group II activator of G-protein signaling (AGS) proteins contain one or more G-protein regulatory motifs (GPR), which serve as docking sites for Gai GDP independent of Gbg and stabilize the GDP-bound conformation of Gai, acting as guanine nucleotide dissociation inhibitors. The GaGPR interaction is regulated by seven-transmembrane-spanning (7TM) receptors in the intact cell as determined by bioluminescence resonance energy transfer (BRET). It is hypothesized that a 7TM receptor directly couples to the GaGPR complex in a manner analogous to receptor coupling to the Gabg heterotrimer. As an initial approach to test this hypothesis, we used BRET to examine 7TM receptor-mediated regulation of GaGPR in the intact cell when Gai 2 yellow fluorescent protein (YFP) was tethered to the carboxyl terminus of the a 2A adrenergic receptor (a 2A AR-Gai 2 YFP). AGS3-and AGS4-Renilla luciferase (Rluc) exhibited robust BRET with the tethered GaiYFP, and this interaction was regulated by receptor activation localizing the regulation to the receptor microenvironment. Agonist regulation of the receptor-Gai-GPR complex was also confirmed by coimmunoprecipitation and cell fractionation. The tethered Gai 2 was rendered pertussis toxin-insensitive by a C352I mutation, and receptor coupling to endogenous Gai/obg was subsequently eliminated by cell treatment with pertussis toxin (PT). Basal and agonist-induced regulation of a 2A ARGai 2 YFP C352I
Introduction
The discovery of the group of proteins defined as activator of G-protein signaling (AGS) in a yeast-based functional screen for mammalian cDNAs that activated G-protein signaling in the absence of a receptor, revealed both unexpected regulatory mechanisms for G-protein signaling systems and expanded functional roles for the G-protein subunits Takesono et al., 1999; Cao et al., 2004; Sato et al., 2006 Sato et al., , 2011 . Group I AGS proteins encompass nonreceptor guanine nucleotide exchange factors, whereas group II AGS proteins, all of which contain a G-protein regulatory (GPR) motif, engage Gai/o/t as guanine nucleotide dissociation inhibitors. Group III AGS proteins appear to engage Gbg, whereas group IV AGS proteins, which were just recently identified, interact with Ga16 (Sato et al., 2011) .
We recently reported that the GaiGPR interaction is regulated by agonist-bound cell surface seven-transmembrane-span (7TM) receptors in the intact cell as determined by bioluminescence resonance energy transfer (BRET) (Oner et al., 2010a,b) . As the GPR motif stabilizes the GDP-bound conformation of Ga free of Gbg, it was hypothesized that a 7TM receptor may directly couple to the GaGPR complex in a manner that is analogous to direct receptor coupling to the Gabg heterotrimer ( Fig. 1A) (Oner et al., 2010a,b; Blumer and Lanier, 2014) . Indeed, the GaGPR complex appears to be positioned in close proximity to the 7TM receptor, and this positioning, which is regulated by agonist, is dependent upon interaction of the GPR protein with Gai (Oner et al., 2010a,b; Vellano et al., 2011) . Alternatively, the regulation of GaGPR observed with receptor activation may be secondary to canonical 7TM receptor coupling to Gabg subsequent to G-protein subunit flux within the microenvironment of a signaling complex (Fig. 1B) . It was also recently postulated that groups I-III AGS proteins may actually represent a signaling triad that parallels that of the well characterized 7TM receptor-Gabg-effector system .
As part of a broader approach to explore these concepts, we examined the 7TM receptor-mediated regulation of the Gai-GPR complex when Gai was actually tethered to the 7TM receptor itself (Fig. 1C) . Thus, the GaiGPR interaction would be highly localized and could also be monitored independent of endogenous Gabg, as the tethered G-protein could be rendered pertussis toxin-insensitive by a single point mutation (Fig. 1D) . The results of these studies suggest direct coupling of a 7TM receptor to the GaGPR complex, which has broad implications for G-protein signal processing.
Materials and Methods
Polyethylenimine (25 kDa molecular mass, linear form) was obtained from Polysciences, Inc. (Warrington, PA). Benzyl-coelenterazine was obtained from NanoLight Technology (Pinetop, AZ). UK14304 [5-bromo-6-(2-imidazolin-2-ylamino)quinoxaline], pertussis toxin, and b-actin antiserum were purchased from Sigma-Aldrich (St. Louis, MO). Gray 96-well Optiplates were obtained from PerkinElmer (Waltham, MA). Green fluorescent protein (GFP) antiserum was obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Gai 1/2 antiserum was provided by Dr. Thomas Gettys (Pennington Biomedical Research Center, Baton Rouge, LA). G-protein-coupled receptor kinase 2 (GRK2) antibody and anti-GFP-Sepharose were obtained from Abcam (Cambridge, MA).
n-Dodecyl-b-D-maltoside was obtained from Cayman Chemical (Ann Arbor, MI). Protease inhibitor mixture tablets (Complete Mini) were obtained from Roche Applied Science (Indianapolis, IN). AGS3 and AGS4 fused at the carboxyl terminus to Renilla luciferase (Rluc) and a 2A adrenergic receptor (a 2A AR) constructs were generated as previously described (Oner et al., 2010a (Oner et al., ,b, 2013a . Rat Gai 2 -yellow fluorescent protein (YFP) was generated by Dr. Scott Gibson (Gibson and Gilman, 2006) and provided by Dr. Nathan Dascal (Tel Aviv University, Tel Aviv, Israel). YFP was inserted within the aB-aC loops in the helical domain of Gai as previously described (Gibson and Gilman, 2006; Oner et al., 2010a,b) . pcDNA3::GRK2-carboxyl terminus (CT) (GRK2-CT), which encodes amino acids Tyr 466 -Leu 689 in the carboxyl terminus of GRK2, was provided by Dr. Jeffrey Benovic (Thomas Jefferson University, Philadelphia, PA). All other reagents and materials were obtained as described elsewhere (Oner et al., 2010a (Oner et al., ,b, 2013a .
Site-Directed Mutagenesis and Plasmid Construction. The a 2A AR-Gai 2 YFP fusion protein was generated by polymerase chain reaction using the human a 2A AR as template and primer sets containing specific sites for restriction enzyme digest as follows: XhoI, a 2A AR forward primer: 59-AAA CTC GAG GCC GCC ACC ATG GGC TCC CTG CAG CCG GAC-39; EcoRI, a 2A AR reverse primer: 59-CAT GGA ATT CTG CAA GCT TCC TCC TCC TCC GGA CAC GAT CCG CTT-39. The reverse primer also encodes an SGGGS linker between a 2A AR and Gai 2 YFP. Digestion of pcDNA3::Gai 2 YFP or pcDNA3::Gai 2 YFP C352I constructs at upstream XhoI/EcoRI sites followed by ligation with the digested receptor linker resulted in inframe construction of the a 2A AR-Gai 2 YFP fusion proteins. C352 in Gai 2 , which is the site of ADP-ribosylation by pertussis toxin (PT), was converted to isoleucine to render the protein PT insensitive by site-directed mutagenesis using the pcDNA3::Gai 2 YFP construct with the following primer set: Gai 2 YFP C352I forward primer: 59-AAC AAC CTG AAG GAC ATT GGC CTC TTC TGA-39; Gai 2 YFP C352I reverse primer: 59-TCA GAA GAG GCC AAT GTC CTT CAG GTT GTT-39. (Burt et al., 1998) . (E) Endogenous Gbg subunits may also engage the a 2A AR-Gai 2 YFP fusion protein (Burt et al., 1998) . GRK2-CT was expressed as a scavenger for free Gbg released subsequent to receptor activation of an a 2A AR-Gai 2 YFP fusion protein complexed with endogenous Gbg. *Receptor activated by agonist.
Cell Culture, Transfection, Immunoblotting, and BRET. BRET measurements and immunoblotting were performed as previously described (Oner et al., 2010a (Oner et al., ,b, 2013a . Forty-eight hours after cell transfection, cells were dispensed in triplicate at 1 Â 10 5 cells/well in gray 96-well Optiplates (Perkin Elmer). Fluorescence and luminescence signals were measured using a TriStar LB 941 plate reader (Berthold Technologies, Oak Ridge, TN) with MikroWin 2000 software (Mikrotek Laborsysteme GmbH, Overath, Germany). Cells were incubated with the a 2 AR agonist (UK14304, 10 mM) or vehicle in Tyrode's solution [140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 0.37 mM NaH 2 PO 4 , 24 mM NaHCO 3 , 10 mM HEPES (pH 7.4), and 0.1% glucose (w/v)] for 5 minutes prior to the addition of coelenterazine h. Coelenterazine h (5 mM final concentration; Nanolight Technology) was added to each well and luminescence measured after 2 minutes (donor: 480 6 20 nm; acceptor: 530 6 20 nm) with the TriStar LB 941 plate reader. Gai 2 YFP or a 2A AR-Gai 2 YFP fusion protein expression was monitored by measuring YFP fluorescence (excitation 485 nm, emission 535 nm). AGS3 and AGS4Rluc expression was monitored by measuring the intensity of the luminescence signal. BRET signals were determined by calculating the ratio of the light intensity emitted by the YFP divided by the light intensity emitted by Rluc. Net BRET values were determined by first calculating the 530 6 20:480 6 20 nm ratio and then subtracting the background BRET signal determined from cells transfected with the donor plasmids phRLuc N3 :: AGS3 or phRLuc N3 ::AGS4 alone. Cell lysates and immunoblotting were performed as previously described (Oner et al., 2010a,b) . Where indicated, cells were incubated with pertussis toxin (100 ng/ml) for 18 hours prior to BRET measurements. Cellular fractionation of UK14304-or vehicle-treated cells by hypotonic lysis and centrifugation were performed as previously described (Oner et al., 2013b) , using HEK293 cells transfected with AGS3 and AGS4 donor plasmids (10 and 2 ng, respectively) and a 2A AR-Gai 2 YFP acceptor plasmid (750 ng) as described earlier.
Immunoprecipitation. HEK293 cells expressing a 2A AR-Gai 2 YFP and AGS3Rluc (1.4 and 0.1 mg of plasmid per well in a six-well plate, respectively) for 24 hours were treated with the a 2 AR agonist UK14304 at a final concentration of 10 mM or with vehicle (Tyrode's solution) for 5 minutes at room temperature and harvested in 4.5 ml of Tyrode's solution. Cells were centrifuged at 500g for 5 minutes, resuspended in 0.5 ml of immunoprecipitation buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA, protease inhibitor cocktail], and sonicated at 50% amplitude for three intervals at 5 seconds each. n-Dodecyl-b-D-maltoside was added to a final concentration of 2%, and membrane proteins were extracted by rotating for 3 hours at 4°C followed by centrifugation at 21,000g for 30 minutes at 4°C. The supernatant was collected and an input sample (1/20 volume; 82.5 mg) taken; to the remaining supernatant (1.65 mg), 25 ml of 50% anti-GFPSepharose (Abcam) was added and rotated overnight at 4°C followed by 6 Â 500 ml resin washes with immunoprecipitation buffer containing 0.2% n-dodecyl-b-D-maltoside. Twenty-five microliters of 5Â Laemmli sample buffer was added to the washed resin, incubated at room temperature for 5 minutes, processed for SDS-PAGE (7% polyacrylamide), transferred to polyvinylidene difluoride membranes, and immunoblotted with AGS3 antisera followed by stripping and reprobing with GFP antisera.
Data Analysis. Statistical significance for differences involving a single intervention was determined by one-way analysis of variance using GraphPad Prism version 4.03 (GraphPad Software, San Diego, CA).
Results and Discussion
As a first step to address the hypothesis regarding direct receptor coupling to Gai 2 GPR, we generated a fusion protein in which Gai 2 YFP was tethered to the carboxyl terminus of the a 2A AR via a flexible glycine linker (Bertin et al., 1994; Wise et al., 1997; Bahia et al., 1998; Burt et al., 1998; Seifert et al., 1999) . We also generated a variant of the a 2A AR-Gai 2 YFP fusion protein that was PT-insensitive (a 2A AR-Gai 2 YFP C352I ). We then examined the ability of GPR proteins to interact with the tethered Gai 2 . AGS3 and AGS4 were selected as representative members of two distinct subgroups of AGS proteins. AGS3 has four GPR motifs downstream of a series of tetratricopeptide repeat domains involved in protein interactions and intramolecular regulatory events, whereas AGS4 is a smaller protein with three full GPR motifs without any clearly defined protein interaction motifs upstream of the GPR motifs.
Both AGS3 and AGS4 interacted with the tethered wild-type and PT-insensitive Gai 2 as indicated by the robust basal levels of BRET (Fig. 2A) . Expression and functionality of a 2A ARGai 2 YFP and a 2A AR-Gai 2 YFP C352I were confirmed by immunoblotting ( Fig. 2A) and agonist-induced phosphorylation of extracellular signal-regulated kinase 1/2 (W. G. Robichaux, III and J. B. Blumer, unpublished data). a 2A AR-Gai 2 YFP:AGS3Rluc BRET and a 2A AR-Gai 2 YFP:AGS4Rluc BRET were not observed with the GPR-insensitive Gai N149I mutant or with AGS3 or AGS4 that was rendered incapable of binding Gai by mutation of a conserved glutamate residue in each of the GPR motifs (AGS3-Q/A and AGS4-Q/A), thus demonstrating the specificity of the interaction (Peterson et al., 2002; Sato et al., 2004; Willard et al., 2008; Oner et al., 2010a,b; W. G. Robichaux, III and J. B. Blumer, unpublished data) .
Incubation of cells with the a 2A AR agonist UK14304 reduced the a 2A AR-Gai 2 YFP:AGS3Rluc BRET by ∼40% (Fig. 2B, left  panel) . Significant agonist-induced reductions in a 2A ARGai 2 YFP:AGS4Rluc BRET were also observed, although not to the same magnitude as that observed for AGS3Rluc (Fig. 2B,  right panel) . Both the basal a 2A AR-Gai 2 YFP:AGS3Rluc BRET and the magnitude of the agonist-induced decrease in BRET observed for AGS3Rluc or AGS4Rluc with tethered Gai 2 YFP were similar to that observed with untethered Gai 2 YFP (similar results were obtained with the a 2A AR-Gai 1 -YFP fusion protein; W. G. Robichaux, III and J. B. Blumer, unpublished data). Thus, these data indicate that a 7TM agonist is regulating a GaGPR complex that is directly anchored to the receptor.
A similar distinction between AGS3 and AGS4 with respect to the magnitude of agonist-induced changes in BRET was also observed with untethered Gai 1 YFP (Oner et al., 2010a,b) . It is not clear if the differences in the magnitude of the agonistinduced changes in GaiYFP:AGS3Rluc versus GaiYFP: AGS4Rluc BRET reflect different coupling efficiencies, stoichiometric considerations, and/or the relative spatial positioning of the acceptor and donor for AGS3 versus AGS4. As an initial approach to address this issue and to verify that the agonistinduced changes in BRET were the result of translocation of GPR proteins away from the receptor-Gai complex, we monitored the subcellular distribution of AGS3Rluc or AGS4R-luc and a 2A AR-Gai 2 YFP by cellular fractionation into crude membranes and cytosol (Fig. 3) . These data indicate that activation of a 2A AR-Gai 2 YFP resulted in translocation of GPR proteins away from the membrane fraction and into the cytosol while a 2A AR-Gai 2 YFP remained in the membrane fraction, Direct Coupling of a 7TM Receptor to GaiGPR suggesting that the observed agonist-induced changes in BRET result from a physical dissociation of GPR proteins from the receptor-Ga complex. The relative extent of AGS3 and AGS4 translocation was almost directly related to the degree of agonistinduced reductions in BRET between AGS3 or AGS4 and a 2A ARGai 2 YFP, as shown in Fig. 2B .
As an additional approach to observe agonist-regulated interaction of GPR proteins with Gai-coupled 7TM receptors, we asked if AGS3 coimmunoprecipitates with a 2A AR-Gai 2 YFP and if this complex was also regulated by agonist. Indeed, AGS3Rluc coimmunoprecipitated with a 2A AR-Gai 2 YFP (Fig.  4) . AGS3-Q/A-Rluc, which cannot bind Gai (Oner et al., 2010a) , did not coimmunoprecipitate with a 2A AR-Gai 2 YFP, thus serving as an important internal negative control. Treatment with the a 2A AR agonist UK14304 resulted in an ∼30% decrease in coimmunoprecipitation of AGS3Rluc with a 2A AR-Gai 2 YFP compared with vehicle treatment. These data further support our hypothesis of an agonist-sensitive 7TM receptor-Gai-GPR complex and the magnitude of the agonist-mediated effects on the complex in the context of coimmunopreciation is roughly similar to the relative magnitude of agonist-mediated effects observed with the BRET studies (Fig. 2B) .
Regulation of the a 2A AR-Gai 2 YFP:GPR-Rluc complex by agonist may reflect the ability of the Gai 2 GPR cassette to directly sense agonist-induced conformational changes in the receptor (Fig. 1C) , as is the case for 7TM receptor coupling to the Gabg heterotrimer. Alternatively, the agonist-induced reduction of a 2A AR-Gai 2 YFP:GPR-Rluc BRET may reflect displacement of AGS3Rluc or AGS4Rluc from the 7TM receptor-Gai 2 YFP fusion protein by Gbg or Ga subsequent to receptor coupling to either endogenous Gabg heterotrimer (Burt et al., 1998) or the a 2A AR-Gai 2 YFP fusion protein where endogenous Gbg is bound to the tethered Gai 2 YFP (Fig. 1E) .
To address these questions, we conducted two sets of experiments. First, we studied the effect of agonist on a 2A ARGai 2 YFP:GPR-Rluc BRET after rendering the tethered Ga subunit PT-insensitive by mutation of the cysteine that is actually ADP ribosylated by pertussis toxin (Fig. 1D) . Such an approach would allow us to eliminate receptor coupling to endogenous Gabg, but retain the coupling integrity of the a 2A AR-Gai 2 YFP C352I fusion protein (Bahia et al., 1998 ). Thus, we have an experimental platform that provides a highly localized readout of receptor-mediated regulation of Gai 2 GPR. : 142,380 6 2980; a 2A AR-Gai 2 YFP C352I + PT: 166,057 6 8005. All BRET data are expressed as mean 6 S.E. from at least three independent experiments with triplicate determinations. Immunoblots are representative of three independent experiments. *P , 0.05 compared with vehicle-treated control group.
The agonist-induced regulation of a 2A AR-Gai 2 YFP:AGS3Rluc or a 2A AR-Gai 2 YFP:AGS4Rluc BRET observed with untethered (W. G. Robichaux, III and J. B. Blumer, unpublished data) or tethered Ga was completely blocked by incubation of cells with PT (Fig. 2B) . However, the agonist-induced regulation of untethered (W. G. Robichaux, III and J. B. Blumer, unpublished data) or tethered Gai 2 C352I was not altered by PT pretreatment, which blocked receptor coupling to endogenous Gai/obg (Fig. 2B) . These data indicate that the agonist-induced regulation of a 2A ARGaiYFP:AGS3Rluc or a 2A AR-GaiYFP:AGS4Rluc BRET is spatially localized and not likely due to exchange of endogenous Gai/o for GaYFP bound to the GPR protein or to the displacement of GaYFP bound to the GPR protein by Gbg subsequent to receptormediated coupling to the Gabg heterotrimer.
In addition to interacting with the GPR proteins AGS3 and AGS4, the a 2A AR-Gai 2 YFP fusion protein may also interact with endogenous Gbg. Agonist-induced activation of the a 2A ARGai 2 YFP:Gbg complex may "release" Gbg, which could potentially displace AGS3 or AGS4 from the a 2A AR-Gai 2 YFP fusion protein, reducing a 2A AR-Gai 2 YFP:GPR-Rluc BRET (Fig. 1E) . To address this issue, we used GRK2-CT to scavenge any Gbg that may be "released" by agonist-induced activation of a 2A ARGai 2 YFP:Gbg (Fig. 5) . GRK-CT expression was confirmed by immunoblotting (Fig. 5B) . Expression of GRK2-CT did not alter the agonist-induced regulation of the BRET observed with AGS3Rluc or AGS4Rluc and the untethered (W. G. Robichaux, III and J. B. Blumer, unpublished data) or tethered Gai 2 YFP (Fig. 5A) . Under similar experimental conditions with untethered Gai 2 YFP, expression of Gbg reduces basal Gai 2 YFP:GPRRluc BRET (Oner et al., 2010a,b) , and this effect of Gbg was reversed by GRK2-CT, providing an internal control that indicates effective Gbg scavenging (Fig. 5B) . The lack of effect of GRK2-CT on agonist-induced regulation of the interaction of GPR proteins with the tethered GaiYFP is consistent with Fig. 3 . Agonist-induced changes in GPR protein distribution. AGS3Rluc (A and B) or AGS4Rluc (C and D) and a 2A AR-Gai 2 YFP were expressed in HEK293 cells as described in Materials and Methods. Cells were incubated with vehicle (Tyrode's solution) or UK14304 (10 mM) for 5 minutes followed by hypotonic lysis, and AGS3Rluc (A) or AGS4Rluc (C) relative luminescence units (RLU) and a 2A ARGai 2 YFP relative fluorescence units (RFU) (B and D) were measured in supernatant (S) and pellet (P) fractions representing crude cytosol and membrane fractions, respectively. AGS3-Q/A and AGS4-Q/A refer to the mutation of a conserved glutamine residue in each of the GPR motifs to alanine, which renders them incapable of binding Gai. *P , 0.05 compared with vehicle. Direct Coupling of a 7TM Receptor to GaiGPR previous observations using untethered GaiYFP (Oner et al., 2010a) . Furthermore, the Gbg inhibitor gallein also did not alter the basal or agonist-regulated BRET between AGS3Rluc or AGS4Rluc and either untethered Gai 2 YFP or Gai 2 YFP tethered to the a 2A AR (W. G. Robichaux, III and J. B. Blumer, unpublished data) . These data suggest that the agonist-induced regulation of the interaction of Gai with GPR proteins does not involve subunit flux subsequent to receptor coupling to Gabg.
Our data suggest that a 7TM receptor couples directly to a GaiGPR complex, ostensibly promoting exchange of GDP for GTP in a manner that may be similar to 7TM receptor engagement of the Gabg heterotrimer. Agonist-mediated activation of a 7TM receptor coupled to GaiGPR apparently results in reversible dissociation of the GPR protein from Gai (Oner et al., 2010a,b) . Upon termination of agonist-induced activation, the GPR protein then reassociates with Gai GDP , representing a cycle that is conceptually analogous to the Gabg activationdeactivation cycle (Oner et al., 2010a (Oner et al., ,b, 2013a . There are several interesting conceptual thoughts that emanate from this work. As regulation of both the GaiGPR complex and the Gaibg heterotrimer is PT-sensitive (Figs. 2 and 3) (Oner et al., 2010a,b) , this raises the intriguing possibility that functional effects associated with PT may be mediated in part by 7TM regulation of GaiGPR complexes. Second, as group II AGS proteins may complex with multiple Ga subunits simultaneously (Bernard et al., 2001; Adhikari and Sprang, 2003; Kimple et al., 2004; Jia et al., 2012) , AGS3 and AGS4 may scaffold receptors and Ga subunits within a larger signaling complex (Jahangeer and Rodbell, 1993; Blumer and Lanier, 2014) . It is interesting to speculate on the relative ratio of receptors coupling to Gabg versus GaGPR. Regulation of GPR protein expression levels may play a role in determining this stoichiometry, as AGS3 and AGS4 levels are responsive to changes in environmental and pathophysiological conditions, including withdrawal from drugs of abuse, ischemia/reperfusion injury, and leukocyte activation (Bowers et al., 2004 (Bowers et al., , 2008 Yao et al., 2005; Nadella et al., 2010; Regner et al., 2011; Kwon et al., 2012; Giguere et al., 2013; Branham-O'Connor et al., 2014; W. G. Robichaux, III and J. B. Blumer, unpublished data) . Additional signals regulating the interaction of Ga with GPR proteins and the subcellular distribution of GPR proteins may also be involved and may provide more rapid and dynamic control of cellular responses (Blumer et al., 2003; An et al., 2008; Nadella et al., 2010; Oner et al., 2010a Oner et al., ,b, 2013c Vural et al., 2010; Giguere et al., 2012) . Finally, of particular interest, the coupling of a receptor to the GaGPR complex or the Gabg heterotrimer may be differentially regulated by hormones, neurotransmitters, and small molecules. and a 2A AR-Gai 2 YFP (250 ng of plasmid) in the absence and presence of Gb 1 , Gg 2 , and/or GRK2-CT (500 ng of each plasmid) as indicated for 48 hours were subjected to BRET measurements, as described in Materials and Methods. All BRET data are expressed as means 6 S.E. from at least three independent experiments with triplicate determinations. Immunoblots are a representative image of three independent experiments. *P , 0.001 compared with control group; † P , 0.001 compared with Gb 1 g 2 -expressing group.
